Nicola Broughton
Founder at Oskare Capital SAS
Profile
Nicola Broughton is the founder and currently holds multiple positions.
She is the Co-Venture Partner at Oskare Capital SAS, which was founded in 2020.
In her current roles, she serves as the Chairman at Wobble Genomics Ltd., Non-Executive Director at Cytomos Ltd., Managing Director at Dr. Broughton Consulting Ltd., Board Member at QUBIS Ltd., Chief Business Officer at Cumulus Oncology Ltd., and Chief Business Officer at Nodus Oncology Ltd.
Dr. Broughton has also held former positions as the Commercial Director at Photopharmica Ltd.
from 2002 to 2012, Investment Director at Mercia Fund Management Ltd., Non-Executive Director at MIP Discovery Ltd.
(United Kingdom) from 2015 to 2020, Non-Executive Director at In-Part Publishing Ltd.
from 2019 to 2020, Non-Executive Director at Manchester Imaging Ltd.
from 2016 to 2018, Non-Executive Director at Medherant Ltd.
from 2015 to 2018, and Non-Executive Director at Invizius Ltd.
from 2018 to 2020.
Dr. Broughton's education includes an undergraduate degree from the University of Oxford in 1994, an MBA from the University of Northumbria in 2000, and a doctorate from King's College London in 1998.
Nicola Broughton active positions
| Companies | Position | Start |
|---|---|---|
QUBIS Ltd.
 QUBIS Ltd. Investment ManagersFinance QUBIS Ltd (Qubis) is a venture capital firm, subsidiary of Queen's University of Belfast founded in the year 1984. The firm is headquartered in Belfast, Northern Ireland. | Director/Board Member | 04/07/2022 |
Nodus Oncology Ltd.
 Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | Corporate Officer/Principal | 31/08/2022 |
Wobble Genomics Ltd.
 Wobble Genomics Ltd. Miscellaneous Commercial ServicesCommercial Services Wobble Genomics Ltd. develops DNA normalization technology to maximize sampling efficiency during sequencing. The company is based in Edinburgh, UK. | Chairman | 30/06/2021 |
Cumulus Oncology Ltd.
 Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Corporate Officer/Principal | 30/06/2020 |
Cytomos Ltd.
 Cytomos Ltd. Miscellaneous Commercial ServicesCommercial Services Cytomos Ltd. provides rapid label-free cell analysis for biotechnology research and in-vitro diagnostics using dielectric spectroscopy. The firm offers ePad technology which permits detection, identification, and characterization of single cells in real-time as they progress through an experiment. The company was founded by Keith Muir and is headquartered in Edinburgh, the United Kingdom. | Director/Board Member | 31/12/2021 |
Oskare Capital SAS
 Oskare Capital SAS Investment ManagersFinance Oskare Capital SAS is an Independent firm. Oskare Capital SAS is headquartered in Paris, France. | Founder | 31/05/2020 |
| Nicola Broughton Consulting Ltd. | Private Equity Investor | 30/04/2020 |
Former positions of Nicola Broughton
| Companies | Position | End |
|---|---|---|
MIP Discovery Ltd. (United Kingdom)
 MIP Discovery Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom. | Director/Board Member | 30/04/2020 |
In-Part Publishing Ltd.
 In-Part Publishing Ltd. Packaged SoftwareTechnology Services In-Part Publishing Ltd. operates a matchmaking platform for university-industry collaboration. It connects businesses with academics looking for university-industry collaboration, technology transfer and research commercialization partnerships. The company was founded by Patrick Speedie and Robin Knight and is headquartered in Sheffield, the United Kingdom. | Director/Board Member | 29/04/2020 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Nicola Broughton
| King's College London | Doctorate Degree |
| University of Northumbria | Masters Business Admin |
| University of Oxford | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Photopharmica Ltd.
 Photopharmica Ltd. Medical SpecialtiesHealth Technology Photopharmica Ltd. develops and discovers novel photosensitizer products. Its products pipeline includes phenothiazinium photosensitizers for use as topical therapeutic antimicrobial agents and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization. The firm's light-activated drugs kill common disease-causing microorganisms including Gram positive and negative bacteria. The company was founded in 2001 by John Lyon and is headquartered in Leeds, the United Kingdom. | Health Technology |
Mercia Fund Management Ltd.
 Mercia Fund Management Ltd. Investment ManagersFinance Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain. | Finance |
Medherant Ltd.
 Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | Health Technology |
QUBIS Ltd.
QUBIS Ltd. Investment ManagersFinance QUBIS Ltd (Qubis) is a venture capital firm, subsidiary of Queen's University of Belfast founded in the year 1984. The firm is headquartered in Belfast, Northern Ireland. | Finance |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | Health Technology |
Wobble Genomics Ltd.
Wobble Genomics Ltd. Miscellaneous Commercial ServicesCommercial Services Wobble Genomics Ltd. develops DNA normalization technology to maximize sampling efficiency during sequencing. The company is based in Edinburgh, UK. | Commercial Services |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
Cytomos Ltd.
Cytomos Ltd. Miscellaneous Commercial ServicesCommercial Services Cytomos Ltd. provides rapid label-free cell analysis for biotechnology research and in-vitro diagnostics using dielectric spectroscopy. The firm offers ePad technology which permits detection, identification, and characterization of single cells in real-time as they progress through an experiment. The company was founded by Keith Muir and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Oskare Capital SAS
Oskare Capital SAS Investment ManagersFinance Oskare Capital SAS is an Independent firm. Oskare Capital SAS is headquartered in Paris, France. | Finance |
| Nicola Broughton Consulting Ltd. | |
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom. | Commercial Services |
In-Part Publishing Ltd.
In-Part Publishing Ltd. Packaged SoftwareTechnology Services In-Part Publishing Ltd. operates a matchmaking platform for university-industry collaboration. It connects businesses with academics looking for university-industry collaboration, technology transfer and research commercialization partnerships. The company was founded by Patrick Speedie and Robin Knight and is headquartered in Sheffield, the United Kingdom. | Technology Services |
Invizius Ltd.
 Invizius Ltd. Packaged SoftwareTechnology Services Invizius Ltd. develops application for dialysis patients. It offers hemo compatibility for dialyzers. The company was founded by Andrew Herbert on January 26, 2018 and is headquartered in Edinburgh, the United Kingdom. | Technology Services |
Manchester Imaging Ltd.
 Manchester Imaging Ltd. Packaged SoftwareTechnology Services Manchester Imaging Ltd. develops dental diagnostic software solutions. It operates as a platform technology underpinning an image analysis software portfolio with development applications in several aspects of dental healthcare. The company was founded by Jim Graham and Hugh Devlin and is headquartered in Manchester, the United Kingdom. | Technology Services |
- Stock Market
- Insiders
- Nicola Broughton
